InvestorsObserver
×
News Home

Is Seagen Inc (SGEN) a Good Buy in the Biotechnology Industry?

Wednesday, March 03, 2021 12:18 PM | InvestorsObserver Analysts

Mentioned in this article

Is Seagen Inc (SGEN) a Good Buy in the Biotechnology Industry?

A rating of 44 puts Seagen Inc (SGEN) near the middle of the Biotechnology industry according to InvestorsObserver. Seagen Inc's score of 44 means it scores higher than 44% of stocks in the industry. Seagen Inc also received an overall rating of 42, putting it above 42% of all stocks. Biotechnology is ranked 44 out of the 148 industries.

Overall Score - 42
SGEN has an Overall Score of 42. Find out what this means to you and get the rest of the rankings on SGEN!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 42 means the stock is more attractive than 42 percent of stocks.

This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Seagen Inc Stock Today?

Seagen Inc (SGEN) stock is trading at $149.65 as of 12:14 PM on Wednesday, Mar 3, a drop of -$4.06, or -2.64% from the previous closing price of $153.71. The stock has traded between $146.90 and $153.33 so far today. Volume today is below average. So far 566,640 shares have traded compared to average volume of 1,306,341 shares.

Click Here to get the full Stock Score Report on Seagen Inc (SGEN) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App